Drug Type Monoclonal antibody |
Synonyms Anti-EpCAM mAb MT201, Human anti-EpCAM monoclonal antibody MT201, Monoclonal antibody MT201 + [3] |
Target |
Mechanism EpCAM inhibitors(Epithelial cell adhesion molecule inhibitors), ADCC(Antibody-dependent cell-mediated cytotoxicity (ADCC) effects) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Adecatumumab | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Phase 2 | FR | 01 Mar 2009 | |
Colorectal Cancer | Phase 2 | DE | 01 Mar 2009 | |
Liver Cancer | Phase 2 | FR | 01 Mar 2009 | |
Liver Cancer | Phase 2 | DE | 01 Mar 2009 | |
Liver metastases | Phase 2 | FR | 01 Mar 2009 | |
Liver metastases | Phase 2 | DE | 01 Mar 2009 | |
Breast Cancer | Phase 2 | - | - | |
Breast Cancer | Phase 2 | - | - | |
Prostatic Cancer | Phase 2 | - | - | |
Prostatic Cancer | Phase 2 | - | - |
Phase 1 | 22 | ligqtbrkym(qczlhuxfbb) = spjgutwizl deeydgfemy (sovdhjekld ) | - | 20 May 2009 | |||
ligqtbrkym(qczlhuxfbb) = itpgloducp deeydgfemy (sovdhjekld ) |